Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

MEDIFAST INC (MED)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow MEDIFAST's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
35.51 +1.80    +5.34%
29/04 - Closed. Currency in USD ( Disclaimer )
Pre Market
28.60
-6.91
-19.46%
8:21:06 - Real-time Data
  • Volume: 633,007
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 34.00 - 36.29
Type:  Equity
Market:  United States
MEDIFAST 35.51 +1.80 +5.34%

MEDIFAST INC Company Profile

 
Get an in-depth profile of MEDIFAST INC, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryFood & Tobacco
SectorConsumer Non-Cyclicals
Employees

874

Equity Type

ORD

Medifast, Inc., through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.

Contact Information

Address 100 International Drive 18th Floor
Baltimore, 21202
United States
Phone 410 581 8042
Fax -

Top Executives

Name Age Since Title
Jeffrey John Brown 61 2015 Lead Independent Director
Daniel R. Chard 56 2016 Executive Chairman & CEO
Scott D. Schlackman 63 2015 Independent Director
Lawrence J. Cheskin - 2008 Chairman of Scientific Advisory Board
J. Graham Thomas - 2022 Member of Scientific Advisory Board
Nikhil Dhurandhar - 2022 Member of Scientific Advisory Board
Elizabeth Geary 42 2023 Independent Director
Jessica Unick - 2022 Member of Scientific Advisory Board
Michael A. Hoer 68 2018 Independent Director
John E. Hayes - - Member of Scientific Advisory Board
John Paul Foreyt - - Member of Scientific Advisory Board
Sylvia B. Rowe - - Member of Scientific Advisory Board
Mark Messina - - Member of Scientific Advisory Board
George A. Bray - - Member of Scientific Advisory Board
Andrea B. Thomas 58 2019 Independent Director
Ming Xian 60 2018 Independent Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MED Comments

Write your thoughts about MEDIFAST INC
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email